China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says
admin China’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency…
Read MoreMerck
Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech
Shares of Imago BioSciences Inc. IMGO, -3.87% soared toward an eight-month high in premarket trading…
Read MoreAmgen, Merck, McDonald's in red even as Dow runs intraday gain to 1,000 points
Amgen, Merck, McDonald’s in red even as Dow runs intraday gain to 1,000 points
Read MoreMerck and Orna Therapeutics to collaborate in deal entitling Orna to up to $3.5 billion in milestone payments
Merck MRK, -0.46% and privately held Orna Therapeutics said Tuesday they have agreed to collaborate…
Read MoreMerck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreMerck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and…
Read More